KTTA – pasithea therapeutics corp. (US:NASDAQ)
Stock Stats
News
Pasithea Therapeutics (KTTA) was downgraded by Zacks Research from "hold" to "strong sell".
Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity [TheStreet.com]
Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity
Pasithea Therapeutics Corp. (KTTA) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript [Seeking Alpha]
Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
Form 10-K Pasithea Therapeutics For: Dec 31
Form SCHEDULE 13G Pasithea Therapeutics Filed by: Coastlands Capital LP
Form 8-K Pasithea Therapeutics For: Feb 20
Form SCHEDULE 13G/A Pasithea Therapeutics Filed by: CVI Investments, Inc.
Form SCHEDULE 13G/A Pasithea Therapeutics Filed by: Squadron Capital Management LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.